Thomas C. Scanlon, Sarah M. Dostal and Karl E. Griswold A high-throughput screen for antibiotic drug discovery Biotechnology and Bioengineering 111
Ultra-high-throughput screen for antibiotic drug discovery. A and B: Environmental DNA is cloned into a vector for heterologous expression in E. coli hosts. C: A microfluidic device is used to generate agarose-in-oil micro-emulsions in which individual recombinant E. coli are co-encapsulated with live bacterial pathogens. D: Droplets in which the recombinant clone secretes a biologic antibiotic are labeled with the SyTox Orange viability probe (orange circles). E: Droplet populations are sorted by FACS to isolate recombinant hosts secreting bactericidal natural products.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf